{"schema_version":"1","generated_at":"2026-11-15T04:18:07.978Z","data_as_of":null,"url":"https://www.findmykol.com/kol/naren-ramakrishna","json_url":"https://www.findmykol.com/kol/naren-ramakrishna/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"naren-ramakrishna","name":"Naren Ramakrishna","credential":"MD, PhD","specialty":"Radiation Oncology","specialty_raw":"Radiation Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"University of Central Florida","institution_url":"https://www.findmykol.com/institution/university-of-central-florida","city":"Orlando","state":"FL","region":{"label":"Southeast","url":"https://www.findmykol.com/region/southeast"}},"identifiers":{"npi":"1194781377","orcid":"0000-0001-7544-7083","openalex":"A5007337539"},"summary":"Naren Ramakrishna is an Oncology physician affiliated with University of Central Florida. OpenAlex indexes 99 publications with 3,153 citations (h-index 28).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":99,"cited_by_count":3153,"h_index":28,"latest_activity_year":2025,"source":"works"},"payments":{"company_count":4,"program_years":{"first":2021,"last":null},"rows_total":14,"shown":3,"withheld":11,"rows":[{"payer":"Novocure","program_year":2025,"amount_usd":1730,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1194781377"},{"payer":"Novocure Inc.","program_year":2025,"amount_usd":31.64,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1194781377"},{"payer":"Brainlab, Inc.","program_year":2025,"amount_usd":22.07,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1194781377"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1194781377","source":"payments"},"prescribing":{"data_year":2023,"areas_total":2,"areas_shown":2,"areas":[{"area":"Sensory organs","share_pct":62.3,"classes_total":1,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":62.3,"drugs":[{"name":"Dexamethasone","share_pct":100}],"max_beneficiaries":22}]},{"area":"Nervous system","share_pct":37.7,"classes_total":1,"classes":[{"class":"N-methyl-D-aspartate Receptor Antagonist","setting":"prescribed","share_pct":37.7,"drugs":[{"name":"Memantine Hcl","share_pct":100}],"max_beneficiaries":11}]}],"care_setting":{"dominant":"facility","data_year":2023,"office_pct":0,"facility_pct":100},"source":"medicare"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Tumor Treating Fields Therapy After Stereotactic Radiosurgery for Brain Metastases From Non-Small Cell Lung Cancer: Final Results of the Phase 3 METIS Study","year":2025,"journal":"International Journal of Radiation Oncology*Biology*Physics","source_url":"https://doi.org/10.1016/j.ijrobp.2025.08.066","status":"verified"},{"title":"Results from METIS (EF-25), an international, multicenter phase III randomized study evaluating the efficacy and safety of tumor treating fields (TTFields) therapy in NSCLC patients with brain metastases.","year":2024,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2024.42.16_suppl.2008","status":"verified"},{"title":"Evaluating Carbon Footprint of Proton Therapy Based on Power Consumption and Possible Mitigation Strategies","year":2023,"journal":"International Journal of Radiation Oncology*Biology*Physics","source_url":"https://doi.org/10.1016/j.ijrobp.2023.05.022","status":"verified"},{"title":"Systemic Therapy for Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: ASCO Guideline Update","year":2022,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.22.00519","status":"verified"},{"title":"Management of Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer and Brain Metastases: ASCO Guideline Update","year":2022,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.22.00520","status":"verified"}],"source":"works"},"similar":[{"name":"Michael Tolentino","slug":"michael-tolentino","institution":"University of Central Florida","specialty":"Retina Specialist","url":"https://www.findmykol.com/kol/michael-tolentino","json_url":"https://www.findmykol.com/kol/michael-tolentino/profile.json"},{"name":"Iswanto Sucandy","slug":"iswanto-sucandy","institution":"University of Central Florida","specialty":"Surgery","url":"https://www.findmykol.com/kol/iswanto-sucandy","json_url":"https://www.findmykol.com/kol/iswanto-sucandy/profile.json"},{"name":"Omar Faour","slug":"omar-faour","institution":"University of Central Florida","specialty":"Endocrinology, Diabetes & Metabolism","url":"https://www.findmykol.com/kol/omar-faour","json_url":"https://www.findmykol.com/kol/omar-faour/profile.json"},{"name":"Nina Tsakadze","slug":"nina-tsakadze","institution":"University of Central Florida","specialty":"Neurology","url":"https://www.findmykol.com/kol/nina-tsakadze","json_url":"https://www.findmykol.com/kol/nina-tsakadze/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Stuart Orkin","slug":"stuart-orkin","institution":"Harvard Medical School","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/stuart-orkin","json_url":"https://www.findmykol.com/kol/stuart-orkin/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":11,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2023}},"methodology_url":"https://www.findmykol.com/about#methodology"}